Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,308 | Dovepress* | 9,436+ | 1,645 | 11,081 | |
PubMed Central* | 872 | 251 | 1,123 | ||
Totals | 10,308 | 1,896 | 12,204 | ||
*Since 24 June 2016 +Since July 2016 |
View citations on PubMed and Google Scholar